Clinical Trials Browser

Phase 2 × Withdrawn × Uveal Melanoma × Clear all

NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2 Withdrawn

Uveal Melanoma, Melanoma

NCT04184518 2020-06-02

CEDUVEAL-M

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

NCT01328106 2017-12-12

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasms